Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.
about
Darunavir: a critical review of its properties, use and drug interactionsBoosted tipranavir versus darunavir in treatment-experienced patients: observational data from the randomized POTENT trial.Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neuronsPharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.A critical review of properties of darunavir and analytical methods for its determination.Darunavir/cobicistat for the treatment of HIV-1: a new era for compact drugs with high genetic barrier to resistance.Lopinavir inhibits insulin signaling by promoting protein tyrosine phosphatase 1B expression.Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.Stability Study of Darunavir Ethanolate Tablets Applying a New Stability-Indicating HPLC Method
P2860
Q26998856-447B2006-1172-4367-B7FA-BD44BD528958Q34050693-5FBCEC27-DD43-4B3D-A406-52621590909EQ35145361-42D686F3-6A94-41C1-A617-6DE7C438E187Q37077340-F89C1B6C-3214-47C4-9B7B-8E71CFBAF8D0Q38267642-1785C7EC-3794-420D-B447-03515396FC76Q38650067-12909939-1D82-4074-BDF4-CD374FAEB19CQ42289070-FA66C8D0-EDE9-415F-8C89-DFA8514F1F3DQ46106006-6622C2A8-09BA-43BD-AB25-4D4787CE87FDQ58920852-4EA67AF9-231B-4279-A8B1-8C74F0EB568B
P2860
Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Efficacy, safety and pharmacok ...... reatment-experienced patients.
@en
Efficacy, safety and pharmacok ...... reatment-experienced patients.
@nl
type
label
Efficacy, safety and pharmacok ...... reatment-experienced patients.
@en
Efficacy, safety and pharmacok ...... reatment-experienced patients.
@nl
prefLabel
Efficacy, safety and pharmacok ...... reatment-experienced patients.
@en
Efficacy, safety and pharmacok ...... reatment-experienced patients.
@nl
P2093
P2860
P50
P356
P1476
Efficacy, safety and pharmacok ...... treatment-experienced patients
@en
P2093
Arkaitz Imaz
Elisabet Deig
Gracia Mateo
Manuel Crespo
Mar Gutirerrez
Pere Domingo
Rosa Maria Lopez
P2860
P304
P356
10.1093/JAC/DKQ295
P407
P577
2010-08-16T00:00:00Z